Trend towards dose reduction of azathioprine as monotherapy in inflammatory bowel disease patients: what about for combination therapy?

Por Williet, Nicolas, Roblin, Xavier
Publicado no Therap Adv Gastroenterol (2016)

Golimumab pharmacokinetics in ulcerative colitis: a literature review

Por Harzallah, Ines, Rigaill, Josselin, Williet, Nicolas, Paul, Stephane, Roblin, Xavier
Publicado no Therap Adv Gastroenterol (2016)

Histopathological and molecular study from EUS fine-needle biopsy of a programmed cell death ligand 1 positive, KRAS mutated pancreatic metastasis

Por Tournier, Quentin, Casteillo, François, Bayle-Bleuez, Sophie, Phelip, Jean-Marc, Williet, Nicolas
Publicado no Endosc Ultrasound (2020)

First Characterization with Ultrasound Contrast Agent of a Fibrovascular Polyp Before Its Endoscopic Resection: A Case Report (with Videos)

Por Williet, Nicolas, Kassir, Radwan, Casteillo, Francois, Yvorel, Violaine, Habougit, Cyril, Roblin, Xavier, Phelip, Jean-Marc
Publicado no Clin Endosc (2019)

Intensification of induction chemotherapy before consolidation chemoradiotherapy improves progression-free survival and time without treatment in patients with locally advanced pan...

Por Williet, Nicolas, Di Bernardo, Thomas, Vernet, Chloé, Roche, Léa Saban, Muron, Thierry, Roblin, Xavier, Magne, Nicolas, Phelip, Jean-Marc
Publicado no Oncotarget (2018)

Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma

Por Williet, Nicolas, Dubreuil, Olivier, Boussaha, Tarek, Trouilloud, Isabelle, Landi, Bruno, Housset, Martin, Botti, Muriel, Rougier, Philippe, Belghiti, Jacques, Taieb, Julien
Publicado em 2011

Difficult endoscopic diagnosis of a pancreatic plasmacytoma: Case report and review of literature

Por Williet, Nicolas, Kassir, Radwan, Cuilleron, Muriel, Dumas, Olivier, Rinaldi, Leslie, Augeul-Meunier, Karine, Cottier, Michèle, Roblin, Xavier, Phelip, Jean-Marc
Publicado no World J Clin Oncol (2017)

The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: validation of a surface biomarker

Por Williet, Nicolas, Petcu, Carmen Adina, Rinaldi, Leslie, Cottier, Michèle, Del Tedesco, Emilie, Clavel, Léa, Dumas, Olivier, Jarlot, Camille, Bouarioua, Nadia, Roblin, Xavier, Peoc’h, Michel, Phelip, Jean-Marc
Publicado no Oncotarget (2017)

Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study

Por Williet, Nicolas, Saint, Angélique, Pointet, Anne-Laure, Tougeron, David, Pernot, Simon, Pozet, Astrid, Bechade, Dominique, Trouilloud, Isabelle, Lourenco, Nelson, Hautefeuille, Vincent, Locher, Christophe, Desrame, Jérome, Artru, Pascal, Thirot Bidault, Anne, Le Roy, Bertrand, Pezet, Denis, Phelip, Jean-Marc, Taieb, Julien
Publicado no Therap Adv Gastroenterol (2019)

Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study

Por Palle, Juliette, Tougeron, David, Pozet, Astrid, Soularue, Emilie, Artru, Pascal, Leroy, Florence, Dubreuil, Olivier, Sarabi, Matthieu, Williet, Nicolas, Manfredi, Sylvain, Martin-Babau, Jerome, Rebischung, Christine, Abdelghani, Meher Ben, Evesque, Ludovic, Dreanic, Johann, Hautefeuille, Vincent, Louafi, Samy, Sefrioui, David, Savinelli, Francesco, Mabro, May, Rousseau, Benoit, Lecaille, Cédric, Bouché, Olivier, Louvet, Christophe, Lecomte, Thierry, Bonnetain, Franck, Taieb, Julien, Zaanan, Aziz
Publicado no Oncotarget (2017)